S100
Tong L, Lan W, Lim RR, Chaurasia SS.
Ocul Surf. 2014 Jan;12(1):23-31
CONJUNCTIVALCHALASIS
(Med Hypotheses. 2013 Nov;81(5):927-30. doi:
10.1016/j.mehy.2013.08.017. Epub 2013 Aug 31.Conjunctivochalasis
is the precursor to pterygium. Tong L1, Lan W, Sim HS, Hou A.
————
Cost of pterygium:
Wlodarczyk J, Whyte P, Cockrum P, Taylor H.
Clin Experiment Ophthalmol. 2001 Dec;29(6):370-5.
————–
Pterygium can cause chronic conjunctival hyperemia, corneal astigmatism, corneal dellen, and impairment of vision.1,2, 0
Hu Q, Qiao Y, Nie X, Cheng X, Ma Y.
Cornea. 2014 Feb;33(2):154-60
1. Manning CA, Kloess PM, Diaz MD, et al.. Intraoperative mitomycin in primary pterygium excision. A prospective, randomized trial. Ophthalmology. 1997;104:844–848. Find Full Text Bibliographic Links [Context Link]
|
|
2. Detorakis ET, Spandidos DA. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (review). Int J Mol Med. 2009;23:439–447.
|
———-
Risk factors for Pterygium:
Liu L, Wu J, Geng J, Yuan Z, Huang D.
BMJ Open. 2013 Nov 19;3(11)
Associated with Pterygium:
Meibomian Gland Disease, Dry Eye
Viso E, Gude F, Rodríguez-Ares MT.
Cornea. 2011 Jan;30(1):1-6.
References
p53 Tumor supressor Gene
4. Tsai YY, Cheng YW, Lee H, et al.. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium. Mol Vis. 2005;11:50–55. Find Full Text Bibliographic Links [Context Link]
CHRONIC INFLAMMATION:
|
|
5. Lan W, Petznick A, Heryati S, et al.. Nuclear factor-[kappa]B: central regulator in ocular surface inflammation and diseases. Ocul Surf. 2012;10:137–148. Find Full Text Bibliographic Links [Context Link]
|
|
6. Park CY, Choi JS, Lee SJ, et al.. Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor. Mol Vis. 2011;17:3468–3480. Find Full Text Bibliographic Links [Context Link]
|
|
7. Torres J, Enríquez-de-Salamanca A, Fernández I, et al.. Activation of MAPK signaling pathway and NF-kappaB activation in pterygium and ipsilateral pterygium-free conjunctival specimens. Invest Ophthalmol Vis Sci. 2011;52:5842–5852.
|
Viruses:
Di Girolamo N. Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia. Eye (Lond). 2012;26:202–211.
UV radiation: 1
- 1
-
Sun exposure and pterygium of the eye: a dose-response curve
-
Am J Ophthalmol, 128 (1999), pp. 280–287
-
1. Moran DJ, Hollows FC. Pterygium and ultraviolet radiation: a positive correlation. Br J Ophthalmol. 1984;68:343–346. Find Full Text Bibliographic Links [Context Link]2. Chao SC, Hu DN, Yang PY, et al.. Ultraviolet-A irradiation upregulated urokinase-type plasminogen activator in pterygium fibroblasts through ERK and JNK pathways. Invest Ophthalmol Vis Sci. 2013;54:999–1007.————————-
- AGE: 2
- 2
-
The prevalence and risk factors for pterygium in an adult Chinese population in Singapore: the Tanjong Pagar survey
-
Am J Ophthalmol, 131 (2001), pp. 176–183
- MALE SEX: 2-3
- 2 &
-
|
|
|
- 3
-
Risk factors for the development of pterygium in Singapore: a hospital-based case-control study
-
Acta Ophthalmol Scand, 78 (2000), pp. 216–220
-
|
- DRY EYE: 4
- 4
-
Pterygium and dry eye
-
Ophthalmologica, 215 (2001), pp. 209–211
-
|
|
infiltration of lymphocytes,5, 6, 7, 8 and 9 especially CD4+ T lymphocytes in both epithelial and stromal layers,5, 6, 7 and 8 as well as CD68+ macrophages in the stromal layer.5 and 9
-
- 5
-
Immunohistochemical HLA-DR antigen expression with lymphocyte subsets and proliferative activity in pterygium
-
In Vivo, 16 (2002), pp. 299–306
-
|
-
- 6
-
The roles of T-lymphocyte subpopulations (CD4 and CD8), intercellular adhesion molecule-1 (ICAM-1), HLA-DR receptor, and mast cells in etiopathogenesis of pterygium
-
Ocul Immunol Inflamm, 11 (2003), pp. 115–122
-
|
|
-
- 7
-
Flow cytometrical analysis of adhesion molecules, T-lymphocyte subpopulations and inflammatory markers in pterygium
-
Ophthalmologica, 220 (2006), pp. 372–378
-
|
|
-
- 8
-
The presence of T-lymphocyte subpopulations (CD4 and CD8) in pterygia: evaluation of the inflammatory response
-
Adv Ther, 25 (2008), pp. 479–487
-
|
|
- 9
-
Pterygium: histological and immunohistochemical aspects
-
Rom J Morphol Embryol, 52 (2011), pp. 153–158
-
|
CHRONIC INFLAMMATORY PROCESS: 10
- 10
-
Pathogenesis of pterygium
-
Eye (Lond), 3 (1989), pp. 218–226
-
|
- ——————-
- 11
-
Current concepts and techniques in pterygium treatment
-
Curr Opin Ophthalmol, 18 (2007), pp. 308–313
-
|
|
- MORPHOLOGY AND FLESHINESS: 12
- 12
-
Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision
-
Arch Ophthalmol, 115 (1997), pp. 1235–1240
-
|
|
- YOUNGER AGE: 13
- 13
-
A randomized trial of conjunctival autografting for pterygium in the tropics
-
Ophthalmology, 96 (1989), pp. 1612–1614
-
|
|
|
OPERATIVE TECHNIQUES: 14-16
-
- 14
-
Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision
-
Ophthalmology, 104 (1997), pp. 974–985
-
|
|
|
-
- 15
-
Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium
-
Br J Ophthalmol, 84 (2000), pp. 385–389
-
|
|
-
- 16
-
The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft
-
Cornea, 23 (2004), pp. 458–463
-
|
|
-
- 17
-
Fibrin glue versus sutures for conjunctival autografting in pterygium surgery: a prospective comparative study
-
Br J Ophthalmol, 92 (2008), pp. 1206–1210
-
|
|
-
- 18
-
Comparison of fibrin glue versus suture for conjunctival autografting in pterygium surgery: a meta-analysis
-
Ophthalmology, 118 (2011), pp. 1049–1054
-
|
|
|
-
- 19
-
Role of conjunctival inflammation in surgical outcome after amniotic membrane transplantation with or without fibrin glue for pterygium
-
Cornea, 27 (2008), pp. 56–63
-
|
|
-
- 20
-
Safety and efficacy of fibrin glue versus vicryl sutures in recurrent pterygium with amniotic membrane grafting
-
Ophthalmic Res, 47 (2012), pp. 23–26
-
|
|
-
- 21
-
Results of intra-operative 0.5mg/ml mitomycin C with 20mg depo steroid in the treatment of primary pterygium
-
Cent Afr J Med, 46 (2000), pp. 330–332
-
- 22
-
Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia
-
Ophthalmology, 108 (2001), pp. 449–460
-
|
|
|
-
- 23
-
Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium
-
Ophthalmology, 113 (2006), pp. 1102–1109
-
|
|
|
-
- 24
-
Postoperative subconjunctival corticosteroid injection to prevent pterygium recurrence
-
Cornea, 27 (2008), pp. 406–410
-
- 25
-
Postoperative conjunctival inflammation after pterygium surgery with amniotic membrane transplantation versus conjunctival autograft
-
Am J Ophthalmol, 152 (2011), pp. 733–738
-
|
|
|
-
- 26
-
Th17 cells in human disease
-
Immunol Rev, 223 (2008), pp. 87–113
-
|
|
-
- 27
-
Interleukin-17 in various ocular surface inflammatory diseases
-
J Korean Med Sci, 26 (2011), pp. 938–944
-
|
|
-
- 28
-
Ocular surface APCs are necessary for autoreactive T cell-mediated experimental autoimmune lacrimal keratoconjunctivitis
-
J Immunol, 187 (2011), pp. 3653–3662
-
|
|
-
- 29
-
Pathogenic role of Demodex mites in blepharitis
-
Curr Opin Allergy Clin Immunol, 10 (2010), pp. 505–510
-
|
|
-
- 30
-
Ocular demodicosis as a potential cause of pediatric blepharoconjunctivitis
-
Cornea, 29 (2010), pp. 1386–1391
-
|
|
-
- 31
-
Correlation between ocular Demodex infestation and serum immunoreactivity to Bacillusproteins in patients with facial rosacea
-
Ophthalmology, 117 (2010), pp. 870–877
-
|
-
- 32
-
Clinical treatment of ocular demodecosis by lid scrub with tea tree oil
-
Cornea, 26 (2007), pp. 136–143
-
|
|
-
- 33
-
Corneal manifestations of ocular Demodex infestation
-
Am J Ophthalmol, 143 (2007), pp. 743–749
-
- 34
-
Tear cytokines and chemokines in patients with Demodex blepharitis
-
Cytokine, 53 (2011), pp. 94–99
-
|
|
|
|
-
- 35
-
Clinical and immunological responses in ocular demodecosis
-
J Korean Med Sci, 26 (2011), pp. 1231–1237
-
|
|
-
- 36
-
High prevalence of ocular Demodex in eyelashes with cylindrical dandruffs
-
Invest Ophthalmol Vis Sci, 46 (2005), pp. 3089–3094
-
|
|
-
- 37
-
Fluorescein dye improves microscopic evaluation and counting of Demodex in blepharitis with cylindrical dandruff
-
Cornea, 26 (2007), pp. 697–700
-
|
|
-
- 38
-
Frequent association of delayed tear clearance in ocular irritation
-
Br J Ophthalmol, 82 (1998), pp. 666–675
-
|
|
-
- 39
-
Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms
-
Ophthalmology, 106 (1999), pp. 803–810
-
|
|
|
-
- 40
-
New grading system to improve the surgical outcome of multirecurrent pterygia
-
Arch Ophthalmol, 130 (2012), pp. 39–49
-
|
|
-
- 41
-
A novel method of tear collection: comparison of glass capillary micropipettes with porous polyester rods
-
Cornea, 16 (1997), pp. 450–458
-
|
-
- 42
-
Management of primary and recurrent pterygium using amniotic membrane transplantation
-
Curr Opin Ophthalmol, 13 (2002), pp. 204–212
-
|
|
-
- 43
-
Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by cultured pterygium head fibroblasts
-
Arch Ophthalmol, 119 (2001), pp. 71–80
-
|
-
- 44
-
Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines
-
Invest Ophthalmol Vis Sci, 41 (2000), pp. 2154–2163
-
|
-
- 45
-
UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells
-
Invest Ophthalmol Vis Sci, 43 (2002), pp. 3430–3437
-
|
-
- 46
-
Th17 cell differentiation: the long and winding road
-
Immunity, 28 (2008), pp. 445–453
-
|
|
|
-
- 47
-
Innate IL-17-producing cells: the sentinels of the immune system
-
Nat Rev Immunol, 10 (2010), pp. 479–489
-
|
|
List of:
quinoline-3-carboxamides
May 2010, 9:107,